Shanghai Henlius Biotech scored its second profitable year in 2024, continuing 2023’s trend after reporting losses in the past.
Henlius Builds Profitability Streak With Second Year In The Black
The Company Has Continued Its Efforts To Build An International Presence
The Chinese player reported its second profitable year in a row, with growth in sales reported across its marketed portfolio and further milestones in the near future.
